课题基金 / 基金详情

UTILITY OF HEMOGLOBIN A1C TO IDENTIFY ED PTS WITHOUT PREVOUSLY DIAG DIABETES

UTILITY OF HEMOGLOBIN A1C TO IDENTIFY ED PTS WITHOUT PREVOUSLY DIAG DIABETES
糖化血红蛋白在无需预先诊断糖尿病的情况下识别 ED PTS 的效用
批准号:
7731300
负责人:
CARLOS A. CAMARGO
金额:
$5.91万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2008-05-31

项目摘要

项目成果

CARLOS A. CAMARGO的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The ED is a novel setting for diabetes screening. We seek to evaluate ED screening for undiagnosed diabetes. In a pilot study at MGH, we will enroll adult ED patients without prior diagnosis of diabetes on 6 data collection days (~600 subjects). The study consists of ED interview, ED POC HbA1c and glucose, and outpatient o-GTT (if ED screening abnormal). We anticipate high rates of undiagnosed diabetes among ED patients and will use these preliminary data for planning a multicenter study of ED diabetes screening.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nasal microRNA during bronchiolitis and age 6y asthma phenotypes: MARC-35 cohort
  • 批准号:
    10267407
  • 项目类别:
  • 资助金额:
    $8.6万
  • 财政年份:
    2020
  • 负责人:
    CARLOS A. CAMARGO
  • 依托单位:
Host genetics, early-life microbiome, and childhood asthma: MARC-43 Boston
  • 批准号:
    10742124
  • 项目类别:
  • 资助金额:
    $87.48万
  • 财政年份:
    2016
  • 负责人:
    CARLOS A. CAMARGO
  • 依托单位:
Nasal microRNA during bronchiolitis and age 6y asthma phenotypes: MARC-35 cohort
  • 批准号:
    9215155
  • 项目类别:
  • 资助金额:
    $178.62万
  • 财政年份:
    2016
  • 负责人:
    CARLOS A. CAMARGO
  • 依托单位:
Airway microbiome and age 6y asthma phenotypes in 2 diverse multicenter cohorts
  • 批准号:
    10242707
  • 项目类别:
  • 资助金额:
    $22.59万
  • 财政年份:
    2016
  • 负责人:
    CARLOS A. CAMARGO
  • 依托单位: